论文部分内容阅读
目的:探讨主动脉球囊反搏器植入术治疗急性左心衰的应用价值。方法:收集我院2013年2月-2016年1月收治的急性左心衰患者102例作为本次研究对象,根据随机信封抽签的方法将患者分为观察组和对照组,每组51例。对照组给予常规药物治疗,观察组在常规药物治疗的基础上加用主动脉球囊反搏器植入术,记录与观察两组患者的临床结局。结果:观察组的总有效率为96.1%,显著高于对照组的总有效率84.3%(P<0.05)。治疗后,观察组与对照组的LVEF值分别为65.22±4.52%和58.20±5.31%,都明显高于治疗前的45.29±5.14%和45.20±4.89%,且观察组的LVEF值明显高于对照组(P<0.05)。观察组治疗后随访6个月的死亡、顽固性缺血、恶性心律失常等近期主要终点事件发生率为5.9%,对照组为21.6%,观察组明显低于对照组(P<0.05)。结论:主动脉球囊反搏器植入术治疗急性左心衰能促进左心室功能的改善,提高治疗效果,减少近期主要终点事件的发生。
Objective: To investigate the value of aortic balloon pump implantation in the treatment of acute left heart failure. Methods: A total of 102 patients with acute left heart failure admitted from February 2013 to January 2016 in our hospital were selected as the subjects. Patients were divided into the observation group and the control group according to random ensemble drawing, with 51 cases in each group. The control group was given conventional drug treatment. The observation group was treated with aortic balloon pump pacemaker implantation based on routine drug treatment, and the clinical outcomes of the two groups were recorded and observed. Results: The total effective rate in observation group was 96.1%, significantly higher than that in control group (84.3%, P <0.05). After treatment, the LVEF values of the observation group and the control group were 65.22 ± 4.52% and 58.20 ± 5.31%, respectively, which were significantly higher than those of 45.29 ± 5.14% and 45.20 ± 4.89% before treatment, and the LVEF values of the observation group were significantly higher than those of the control group Group (P <0.05). The incidence of death, refractory ischemia and malignant arrhythmia in the observation group was 5.9% after 6 months of follow-up, compared with 21.6% in the control group. The observation group was significantly lower than the control group (P <0.05). Conclusion: Aortic balloon pump implantation for acute left heart failure can improve the left ventricular function, improve the therapeutic effect and reduce the occurrence of the recent major end-point events.